High blood pressure, one of the most common chronic diseases in industrialized societies, is a primary risk factor for cardiovascular disease, heart failure, renal disease and stroke. 
primary risk factor for cardiovascular disease, heart failure, renal disease and stroke. It had been demonstrated that acute hypercalcemia produced a rise in arterial pressure in normal subjects and in individuals with renal disease.5 An association between high blood pressure and primary hyperpara thyroidism was documented in the surgical literature.6 By the mid-1970s, the control of vascular smooth muscle contraction was known to be related to the release of intracellular stores of calcium. In addition, it was generally believed that "salt" is the only dietary factor that contributes to hypertension. Thus, the concept of a circulating inhibitor of sodium transport dominated the explanation of how sodium intake was linked with increased intracellular calcium concentration and an obligatory increase in smooth muscle contractility.8 The sodium inhibitor hypothesis lead scientists to speculate that intracellular-free calcium was elevated in the vascular tissue of experimental models and humans with high blood pressure.9
In This review summarizes the data that have accumulated since the calcium hypothesis was proposed that relate calcium nutrition and metabolism to the control of arterial pressure in humans. Our understanding in this area has been expanded in recent years to recognize the critical effects of interactions between calcium and sodium that play pivotal roles in the development and treatment of human hypertension. Further, it is now reasonable to speculate on specific applications of this information to populations at high risk of developing hypertensive cardiovascular disease. Much of the content is based upon several earlier reviews by our laboratory on this subject.11-13 Epidemiology Biochemical parameters
The first reported clinical investigation in this area characterized a small increase in circulating parathyroid hormone (PTH) levels in untreated essential hypertension compared to normotension despite similar serum total calcium.1 This increase could not be attributed to renal dysfunction, but was associated with an inappropriate increase in urinary calcium excretion (UCaV) when indexed against simultaneous urinary sodium excretion, and was characterized as a "renal calcium leak" in hyper tension. Other studies have also noted an increase in UcaV in hypertension,14,15 and many have confirmed the existence of a defect in renal calcium handling.16-18 Results of a study from our laboratory, carried out under close metabolic conditions, appear to exclude an abnormal increase in intestinal calcium handling as the explanation and demonstrate that UcaV correlates very well with blood pressure.18
Several reports have extended the observation that increased UCaV characterizes specific subpopulations at risk for developing high blood pressure. Offspring of hypertensive subjects exhibit a transient hypercalciuria when ingesting a high salt diet.19,20 African-Americans with hypertension compared to normotension have sig nificantly higher UCaV.21 Normotensive adults on a potassium-restricted diet develop a renal calcium leak at the same time mean arterial pressure rises and sensitivity to infused NaCl emerges.22 Further, Cappuccio et al23 have reported that hypertension is more prevalent in subjects with hypercalcuric nephrolithiasis, which would be anticipated if high blood pressure and hypercalciuria were pathogenetically linked to one another.
Subsequent studies have also shown an increase in PTH in hypertension.24-26 In a cross-sectional study, Grobbee et al24 documented that PTH hormone values were positively correlated with blood pressure after adjustment for weight in young males. In a separate group of individuals with early mild hypertension, these investigators found a continuous, positive relationship of PTH and blood pressure, independent of weight.25 The ratio of calcium and ionized calcium to PTH was related to blood pressure in a study by Zachariah et al26 suggest ing abnormal regulation of PTH activity. A simultaneous increase in PTH, urinary cAMP, and UcaV in hyper tension was confirmed by Strazzullo et al14 and by Ellison et al27 Young et al28 have documented subtle increases in PTH concentrations in hypertensive males but not females. Brickman et al29 have also reported increased PTH concentrations in essential hypertension. Krishna et al22 observed an increase in PTH levels in normal adults on low potassium diets who then express a modest increase in blood pressure when subjected to a saline infusion.
Serum ionized calcium values have been reported to be identical, modestly decreased, or increased in hyper tensive as compared to normotensive subjects. We initially reported significantly lower ionized calcium levels in hypertension versus normotension;30 this was confirmed by Folsom and coworkers31 who found that ultrafiltrable calcium and serum ionized calcium tended to be lower in persons with higher blood pressure. The relationship between serum ionized calcium and blood pressure is continuous over a wide age range. An inverse correlation between ionized calcium and blood pressure has been demonstrated in the general population,32,33 as well as in adolescents34 and the elderly. 35 Resnick et al36 speculated that any relationship that might exist between serum ionized calcium and blood pressure was dependent upon the simultaneous renin status; patients with low renin hypertension have lower ionized calcium as compared to patients with high renin hypertension who have higher ionized calcium values. Strazzullo et al37 noted that although baseline serum ionized calcium was virtually identical between normo tensive and hypertensive subjects, serum ionized calcium concentration increased less in hypertensive than in normotensive subjects following a calcium infusion. Lower serum ionized calcium concentrations have recently been reported in women with gestational hypertension and preeclampsia. 38 Some epidemiological surveys have demonstrated no relationship between blood pressure and ionized calcium levels,39-41 while others have noted an increase in serum ionized calcium in hypertensive as compared to normo tensive subjects.42,43 Methodologic variations likely explain these discrepant results. Of particular importance may be the dietary status of subjects; the results of our metabolic study are consistent with an effect of diet.18 In that protocol, hypertensive and normotensive persons on self-selected diets exhibited no difference in serum ionized calllum levels. However, when subjects were placed on control diets of either 400mg or 1400mg calcium for 9days, a consistent difference in serum ionized calcium concentrations was observed. The import ance of strict metabolic conditions to detect differences in serum ionized calcium is supported by the fact that in those studies employing such standards, differences have been consistently noted. 18.19,29.38 The relationship of serum phosphorus to high blood pressure has been quite consistent. Reports have ident ified lower serum phosphorus levels in subjects with hypertension and/or a continuous inverse correlation between serum phosphorus concentration and blood pressure. 1, 18, 29, 30 The depression in serum phosphorous is a predictable counterpart to the increased PTH levels noted above.
Limited assessments of vitamin D metabolism been carried out in patients with essential hypertension. Sowers et al44 found a significant inverse relationship between dietary vitamin D levels and blood pressure, independent of other factors. In a subsequent report, these investigators reported that serum levels of I,25(OH)2 vitamin D3 were directly related to blood pressure in 373 women, and could explain 7% of blood pressure variation. Young et al228 reported lower 1,25(OH)2 vit amin D3 levels in hypertensive compared to normal males; no differences were observed in the females. In another study, these investigators 18 detected no difference in vitamin D3 levels between hypertensive and normo tensive men. However, since the hypertensive subjects in this study exhibited increased UcaV and low serum calcium concentrations, it could concluded that 1,25(OH)2 vitamin D3 levels were inappropriately low in the hyper tensive subjects. Brickman et al29 observed higher 1, 25 Overall, the subtle pattern of biochemical abnormali ties is consistent with an abnormal regulation of the PTH-vitamin D axis in the clinical setting of high blood pressure, which appears to precede the emergence of hypertension. Collectively, the findings support the conclusion that within the population of subjects with high blood pressure or at risk of developing hypertension there is a subset that would likely require a greater daily intake of calcium in order to maintain their calcium balance compared to individuals with normal blood pressure.
Dietary calcium
In the first published study of dietary calcium intake in hypertensive as compared to normotensive individuals, we found that hypertensive subjects had significantly lower dietary calcium intake as compared to normo tensive subjects.47 Of the nutrients measured, only calcium intake differed between the 2 groups. We subsequently confirmed this observation,48 using the database from the National Health and Nutrition Examination Survey I (NHANES I), a population sample of the U.S. non institutionalized civilian population conducted in 1973 . Of the nutritional factors assessed in that survey, dietary calcium was the best predictor of the presence of hyper tension. As the reported level of dietary calcium con sumption increased, there was a lower probability of having high blood pressure . The relationship was evident in adult males at all ages; for females it was most evident above the age of fifty. This interaction between sodium and calcium has been investigated in a second database by Hamet et al51 and confirmed recently from China.52 In this study the lowest blood pressures observed were in those subjects con suming both a high sodium chloride (NaCl) and high calcium diet. Thus it appears that consumption of ad equate (>800-1100mg/day) calcium may protect against NaCl-induced hypertension.
Criqui Overall, a significant blood pressure reduction was observed in at least a segment of the population in 75% of these trials. This assessment has been confirmed by a meta-analysis from the Epidemiology Branch of the NHLBI.65 Blood pressure reduction with calcium sup plementation has ranged from 2 to 10mmHg. Based on the NHLBI analysis, the blood pressure lowering effect of increasing calcium intake is equally as great or even greater in normotensive subjects as in the hypertensive subject, and a dosss-dependent effect was identified. Primarily a systolic blood pressure effect is observed. The conclusion from the NHLBI analysis is consistent with the graphic portrayal of Grobbee's meta-analysis64 and the conclusions of Mikami et al.66 The studies that have reported the most significant blood pressure reductions have included more than 50 subjects overall, and were randomized, placebo-controlled studies. In other reports, including many of the negative studies, the sample size was insufficient to detect the small blood pressure reductions observed with nonphar macologic interventions such as calcium supplementation, and in some cases only one blood pressure determination during the intervention phase was recorded. The length of supplementation may be very important to determine a positive effect on blood pressure. In our first clinical trial, we noted a significant blood pressure reduction only after 8 weeks of supplementation, though not after 6 weeks.67 Contrary to this, two negative trials by Bloomfield et albs and Cappuccio et al69 used only 4 weeks of calcium supplementation. Although two trials were only 1-2 weeks in duration, significant blood pressure reductions were detected either because of a higher level of supplementation 70 or more intensive observation on a metabolic ward.71
Since the epidemiological data indicate that a threshold may exist for the effect of dietary calcium on blood pressure, it follows that studies employing subjects whose normal intakes exceed this threshold would be unlikely to reveal an impact of increased calcium. Several of the trials intervened in populations where baseline calcium intake was already very high, 71 not surprising, none of them showed a positive outcome. Specifically, the results from the TOHP Study are consistent with that trend. In that study subjects with high normal blood pressures who received calcium supplementation failed to have a statistically significant fall in their blood press ure.75 Based on the information in the published report, the majority of the subjects were already consuming levels of dietary calcium exceeding the 400-600mg/day threshold. Our own report of supplementation in young normotensive subjects is consistent with the TOHP outcome;76 the normotensive participants reported aver age dietary calcium >900mg/day. In our trial comparing a placebo to either 1000mg of supplemental calcium or a diet designed to increase calcium intake to 1000mg through foods in subjects with mild hypertension and average calcium intake below that of normotensive subjects, systolic blood pressure was significantly reduced in both groups (Morris CD, personal communication).
Although the blood pressure reductions observed in reported clinical trials have been moderate, with a range of mean changes of 3-15mmHg, when projected across the population, these changes could represent significant benefits in overall cardiovascular morbidity and mortality. The response to calcium supplementation is Gaussian, representing larger changes in blood pressure for some individuals. Similarly, as with most antihypertensive interventions, some individuals are either resistant to the treatment or actually experience a blood pressure rise . This heterogeneous response to increased calcium is similar to that observed in clinical trials for sodium restriction, potassium supplementation, and diuretic use.79 Clearly, even where large trials have failed to demonstrate an overall effect, the existence of calcium sensitive subpopulations is evident and must be explored .
Predictors of a Blood Pressure Response
A variety of demographic, biochemical, and nutritional parameters have been assessed in an endeavor to predict blood pressure response to calcium supplementation . Although male subjects appear to be slightly more sensi tive than females, this difference is not firmly established . In a trial with both African-American and Caucasian subjects, there was no difference in blood pressure re sponse based on races" However , the clinical experience of Zemel et al81 suggests that, indeed , African-Americans more than Caucasians would benefit from the cardio protective effects of increased calcium intake.
Of the biochemical parameters , serum ionized Laicium has not been a predictor of a blood pressure response although in our initial trial those subjects who had the DA: Calcium Metabolism in Hypertension smallest change in ionized calcium had the largest drop in blood pressure.67 Resnick et al82 have reported that blood pressure reduction is dependent on renin status. Low-renin (sodium expanded) hypertensive subjects have the greater blood pressure reductions and high-renin hypertensive subjects may experience a pressor effect, although this has not been confirmed in other studies. If this is ultimately demonstrated to be the case, it wouldddovide a critical piece of evidence to support a relationship between sodium-sensitivity and calcium supplementation.
Grobbee and Hofmans3 reported that subjects below the median for serum total calcium had a greater blood pressure response compared to those above the median. Similarly, subjects in their study who were above the median PTH level had greater reductions in blood press ure. Lyle et al 14 observed an identical pattern is relation ship for PTH as well as for serum total calcium values, and the blood pressure response to calcium supplemen tation. Repke et al 15 have also observed that low serum calcium and elevated PTH appear to be predictive of a blood pressure reduction in gestation. 
Areas of Potential Clinical Application
Sodium-sensitive hypertension: Understanding the pathogenesis and treatment of hypertension induced by NaCl remains a primary challenge to cardiovascular researchers. Kurtz and co-workerss8 demonstrated that NaCl-sensitive hypertensive subjects develop increased urinary calcium similar to that observed in the DOCA -saline and Dahl sodium-chloride dependent experimental models. Oshima and colleagues89 have reported a remarkable relationship between salt sensitivity and increased intracellular calcium concentration. Shingu et al90 reported a similar relationship in platelets of humans. Oshima et al91 have documented that the impact of NaCl on platelet intracellular calcium can be reversed by increasing dietary calcium. These findings provide a subcellular link between salt sensitivity in human hypertension and cellular calcium metabolism.
The observation that calcium supplementation lowers blood pressure in various animal models of NaCl-related hypertension92,93 provides compelling laboratory evidence that provision of adequate calcium may afford protection against NaCl-induced hypertension. This proposition, first suggested in humans by Resnick et al,94 has been confirmed by Saito et al95,96 in two separate studies; provision of supplemental calcium to subjects ingesting a high salt diet prevented any rise in blood pressure as well as platelet hvperaggregability, a risk factor for stroke.
In light of recent reports of adverse effects of sodium restriction for the treatment of hypertension, the inter active, and potentially protective effects of adequate calcium in this setting take on even greater importance. The most compelling of these reports is the 1995 publi cation by Alderman et al97 who found in a prospective study of more than 2,000 treated hypertensive individuals, that the incidence of myocardial infarction and total cardiovascular disease was significantly higher in those with urinary sodium excretion in the lowest quintile relative to those with sodium excretion in the highest quintile (range 35-340mmol).
After controlling for a variety of potential confounding factors, the risk remained significant. Other reported adverse effects of restricted sodium include increased serum lipids,98 impaired efficacy of the calcium channel blocker class of antihypertensive medications,99 and increased circulating insulin levels.100
Pregnancy-induced hypertension (PIH): PIH is an important clinical problem to which the concepts out lined here may be of critical value. Disturbances of calcium metabolism have been identified in human pregnancy,101-104 many of which are similar to those observed in essential hypertension. PIH patients fail to increase circulating vitamin D3 and PTH levels and as a consequence may not be able to adequately defend their calcium homeostasis. This could be potentially harmful if their average daily calcium intake is less than adequate. Zemel et al105 have reported recently that within the first 3 months of gestation, an increase in platelet free intracellular calcium strongly predicts a pathological increase in late-term blood pressure , confirming earlier suggestions of such a defect.103,104 This finding suggests that a preexisting disturbance of cell regulation of calcium underlies the pathogenesis of PIH and prematurity . African-Americans: Alterations in calcium metabolism may be particularly important for the pathogenesis of hypertension in African-Americans.111,112 Dietary calcium intake among African-Americans in this country is sig nificantly less than that observed in Caucasians.67,13 One epidemiological study has demonstrated that after correcting for differences in calcium intake, one can account for a large proportion of variation in blood pressure between adolescent Caucasian and African American females.113 The sentinel observations of Zemel et al111,112 suggest a beneficial effect of calcium intake on blood pressure control and cardiovascular regulation in hypertensive African-American diabetic patients. Ernst et al114 reported that increasing dietary calcium intake prevents stress-induced increases in mean arterial pressure in African-Americans.
Adult-onset type 11 diabetes mellitus: Adult-onset type II diabetes mellitus poses a serious threat to many adults in terms of premature cardiovascular disease, both cardiac and cerebrovascular events. Hypertension is the principal co-factor in 80% of its victims. Recent experience in human subjects81 indicates a remarkable potential for intervening with dietary calcium to lower blood pressure and improve cardiac hypertrophy. This is backed by several reports in experimental animals115,116 that suggest a strong overlap among dysregulation of blood pressure, calcium metabolism, and carbohydrate metabolism. Given that African-Americans, overweight persons, and the elderly are likely to develop insulin resistant diabetes and also generally have low calcium intake, this association seems even more worthy of pursuit. Byyny et ally have provided further cellular evidence for this link. Re setting the calcium intake threshold to a higher obligatory level would be dictated by the impaired active calcium transport in the gut that is well established in diabetes.
Hypertension prevention: Perhaps the most important application of the findings outlined above is the extent to which maintenance of the recommended daily allowance (RDA) for calcium will prevent the blood pressure in crease occurring with age in industrialized societies, and the subsequent morbidity and mortality. Our current understanding in this area of investigation clearly indi cates that intake of dietary electrolytes plays a major role in blood pressure regulation. This is evidenced by the most recent report of the NHLBI Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure,18 in which adequate intake of dietary nutrients including calcium, potassium, and magnesium is recommended for use in both hypertension treatment and prevention. This may be particularly ben eficial in groups with chronic low consumption of dietary calcium such as women, African-Americans, under nourished infants and children, as well as many elderly individuals.
Summary
Pathological alterations in calcium metabolism are a factor in abnormal blood pressure regulation in some humans. A consistent nutrient/blood pressure association has been demonstrated in epidemiological studies, the strength of which has been acknowledged by leading authorities in the field of nutritional epidemiology. Thus, in patients with mild to moderate hypertension, dietary calcium intake should be assessed, and where appropriate, they should be encouraged to maintain intake levels of 800 to 1000mg/day. More importantly, for normal subjects at risk of developing high blood pressure, in adequate intake of dietary calcium should be avoided. It is clear that the maintenance of the recommended daily calcium intake is essential for optimal blood pressure control as well as bone and cardiovascular health. As the accumulated evidence suggests, it is the prevention of calcium deficiency that should be strived for in patients with essential hypertension or individuals at risk of developing this all-too-common medical disorder . Ad equate intake should be promoted of not only calcium , but also potassium, magnesium, phosphorus and essential fatty acids. The published scientific data summarized here support this conclusion as well as the implementation of strategies to effect such an outcome in order to improve cardiovascular health in humans . DA 
